Coronavirus: Commission secures an agreement with BioNTech-Pfizer to adapt delivery schedules to Member States' needs

Published on 13 May 2022

European Commission Press release Brussels, 13 May 2022 Today, the European Commission and the vaccine developers, BioNTech and Pfizer, reached an agreement to better address Member States needs for COVID-19 vaccines for the months ahead.